Antibody-Mediated Protection against Cytotoxic T-Cell Escape in Coronavirus-Induced Demyelination

Journal of Virology

Volumn 77, Issue 22, 2003, Pages 11867-11874

  Dandekar, Ajai A ^a   Jacobsen, Gary ^b   Waldschmidt, Thomas J ^a,b   Perlman, Stanley ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DEMYELINATING DISEASE; HAPLOTYPE; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; MOUSE STRAIN; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; B-LYMPHOCYTES; BRAIN; DEMYELINATING DISEASES; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; MURINE HEPATITIS VIRUS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0242363263     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.22.11867-11874.2003     Document Type: Article

References (34)

1. Banner, L., J. G. Keck, and M. M. C. Lai. 1990. A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175:548 to 555.
2. Bergmann, C., M. McMillan, and S. A. Stohlman. 1993. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol. 67:7041-7049.
3. Borrow, P., and G. M. Shaw. 1998. Cytotoxic T-lymphocytes escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol. Rev. 164:37-51.
4. Castro, R. F., G. D. Evans, A. Jaszewski, and S. Perlman. 1994. Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology 200:733-743.
5. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
6. Desrosiers, R. C. 1999. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nat. Med. 5:723-725.
7. Erickson, A. L., Y. Kimura, S. Igarashi, J. Eichelberger, M. Houghton, J. Sidney, D. McKinney, A. Sette, A. L. Hughes, and C. M. Walker. 2001. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15:883-895.
8. Heyman, B. 2000. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18:709-737.
9. Jacobsen, G., and S. Perlman. 1990. Localization of virus and antibody response in mice infected persistently with MHV-JHM. Adv. Exp. Med. Biol. 276:573-578.
10. Karlsson, M. C., S. Wernersson, T. Diaz de Stahl, S. Gustavsson, and B. Heyman. 1999. Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. Proc. Natl. Acad. Sci. USA 96:2244-2249.
11. Klenerman, P., F. Lechner, M. Kantzanou, A. Ciurea, H. Hengartner, and R. Zinkernagel. 2000. Viral escape and the failure of cellular immune responses. Science 289:2003.
12. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162:7358-7368.
13. Matthews, A., S. R. Weiss, M. Shlomchik, L. Hannum, J. Gombold, and Y. Paterson. 2001. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J. Immunol. 167:5254-5263.
14. McMichael, A. J., and R. E. Phillips. 1997. Escape of human immunodeficiency virus from immune control. Annu. Rev. Immunol. 15:271-296.
15. + T-cell subset that responds to viral glycoproteins. Virology 187:443-452.
16. O'Connor, D. H., T. M. Allen, T. U. Vogel, P. Jing, I. P. DeSouza, E. Dodds, E. J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, H. Horton, N. Wilson, A. L. Hughes, and D. I. Watkins. 2002. Acute phase cytotoxic T-lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493-499.
17. Pace, G., and D. Dresser. 1961. The elimination of mouse and bovine globulins from the circulation of newborn and adult mice. Q. J. Exp. Physiol. 46:369-375.
18. Parker, M. M., and P. S. Masters. 1990. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology 179:463-468.
19. Parker, S. E., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173: 664-673.
20. Perlman, S., R. Schelper, E. Bolger, and D. Ries. 1987. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb. Pathog. 2:185-194.
21. Perlman, S., and G. Wu. 2001. Selection of and evasion from cytotoxic T-cell responses in the central nervous system, p. 219-242. In M. Buchmeier and I. Campbell (ed.), Neurovirology: viruses and the brain. Academic Press, San Diego, Calif.
22. Pewe, L., G. Wu, E. M. Barnett, R. Castro, and S. Perlman. 1996. Cytotoxic T-cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253-262.
23. Pewe, L., S. Xue, and S. Perlman. 1997. Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. J. Virol. 71:7640-7647.
24. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R. Zinkernagel. 1990. Viral escape by selection of cytotoxic T-cell-resistant virus variants in vivo. Nature 346:629-633.
25. Price, G. E., R. Ou, H. Jiang, L. Huang, and D. Moskophidis. 2000. Viral escape by selection of cytotoxic T-cell-resistant variants in influenza A virus pneumonia. J. Exp. Med. 191:1853-1867.
26. Ramakrishna, C., S. A. Stohlman, R. D. Atkinson, M. J. Shlomchik, and C. C. Bergmann. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J. Immunol. 168:1204-1211.
27. Schwender, S., H. Imrich, and R. Dorries. 1991. The pathogenic role of virus-specific antibody-secreting cells in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology 74:533-538.
28. Shinall, S. M., M. Gonzalez-Fernandez, R. J. Noelle, and T. J. Waldschmidt. 2000. Identification of murine germinal center B-cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164: 5729-5738.
29. Stohlman, S. A., C. C. Bergmann, and S. Perlman. 1998. Mouse hepatitis virus, p. 537-557. In R. Ahmed and I. Chen (ed.), Persistent viral infections. John Wiley & Sons, New York, N.Y.
30. Street, N., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171-177.
31. Sun, N., and S. Perlman. 1995. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69:633-641.
32. Tao, T. W., and J. Uhr. 1966. Capacity of pepsin-digested antibody to inhibit antibody formation. Nature 212:208-209.
33. Tschen, S. I., C. C. Bergmann, C. Ramakrishna, S. Morales, R. Atkinson, and S. A. Stohlman. 2002. Recruitment kinetics and composition of anti-body-secreting cells within the central nervous system following viral encephalomyelitis. J. Immunol. 168:2922-2929.
34. Tyor, W. R., and D. E. Griffin. 1993. Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice. J. Neuroimmunol. 48:37-44.